TipRanks on MSN
Daiichi Sankyo’s New Study on Cardiovascular Drug Combination: A Market Game-Changer?
Daiichi Sankyo Company (($DSKYF)) announced an update on their ongoing clinical study. Daiichi Sankyo Company is conducting a study titled ‘A ...
A massive genetic study found that naturally lower cholesterol is linked to a dramatically reduced risk of dementia. The ...
Having lower cholesterol levels may help protect against dementia, according to a large-scale international study led by the ...
Reducing cholesterol levels might not just be good for your heart; they might also be effective at reducing your risk of ...
A new study led by the University of Bristol, involving more than one million participants, has found that having lower cholesterol levels may reduce the risk of developing dementia. The study, led by ...
The drug sulthiame reduces the number of breathing pauses and improves sleep quality in patients with obstructive sleep apnea, according to a European clinical study in which the University of ...
Digital health platform Hello Heart is launching a new suite of medication management tools for people at risk of heart disease, including an AI assistant for heart health. Through a connected blood ...
Elaine Chen covers biotech, co-writes The Readout newsletter, and co-hosts STAT’s weekly biotech podcast, The Readout Loud. You can reach Elaine on Signal at elaineywchen.70. A troubled Indiana ...
Researchers at the University of Barcelona found that combining pemafibrate and telmisartan significantly reduces liver fat and cardiovascular risks in MASLD models. The drug duo works better together ...
California Gov. Gavin Newsom on Saturday signed Senate Bill 41, a bill that would impose regulations on insurance-industry middlemen who are accused of driving up prices for prescription drugs, and ...
Pharmaceutical giant AstraZeneca will offer U.S. patients discounted prices for some prescription drugs, President Trump announced Friday, the second major drug company to strike a deal with the Trump ...
Almost every Senate Republican on Thursday urged the Food and Drug Administration (FDA) to “reevaluate” whether a newly approved generic version of the abortion drug mifepristone should stay on the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results